conivaptan has been researched along with cardiovascular agents in 5 studies
| Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 188 | 17 | 64 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, K; Iizumi, Y; Inagaki, O; Kusayama, T; Tahara, A; Tanaka, A; Tokioka, T; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T | 1 |
| Schweiger, TA; Zdanowicz, MM | 1 |
| Abrahams, Z; Chen, SY; Gonzalez-Stawinski, GV; Hobbs, R; Mullens, W; Sokos, GG; Taylor, DO | 1 |
| Boddu, SH; Churchwell, MD; Howard, MS; Mauro, VF | 1 |
| Fan, G; Han, J; Orgah, J; Wang, X; Yang, M; Zhang, B; Zhu, J; Zhu, Y | 1 |
1 review(s) available for conivaptan and cardiovascular agents
| Article | Year |
|---|---|
Vasopressin-receptor antagonists in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan | 2008 |
4 other study(ies) available for conivaptan and cardiovascular agents
| Article | Year |
|---|---|
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiac Pacing, Artificial; Cardiovascular Agents; Diuresis; Dogs; Female; Heart Failure; Hemodynamics; Male; Receptors, Vasopressin; Renal Agents | 1999 |
Conivaptan: potential therapeutic implications in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Diuretics; Heart Failure; Hormone Antagonists; Humans; Patents as Topic; Treatment Outcome; Water-Electrolyte Balance | 2008 |
Compatibility of conivaptan injection with select cardiovascular medications.
Topics: Benzazepines; Cardiovascular Agents; Contraindications; Dobutamine; Dopamine; Drug Combinations; Drug Incompatibility; Humans; Infusions, Intravenous; Milrinone; Nitroglycerin | 2014 |
Danhong injection attenuates cardiac injury induced by ischemic and reperfused neuronal cells through regulating arginine vasopressin expression and secretion.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cardiovascular Agents; Cell Hypoxia; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Glucose; Mitochondria; Myocytes, Cardiac; Neurons; Neuroprotective Agents; Rats, Wistar; Receptors, Vasopressin | 2016 |